Anti-Orthopoxvirus Activity of Amantadine and Rimantadine Derivatives—In Vitro Testing and Molecular Modeling

In 2022, the number of mpox cases spiked worldwide, leading to a surge in scientific research on members of the Orthopoxvirus genus and the discovery of new compounds exhibiting anti-orthopoxvirus activity. This work is devoted to the synthesis of compounds containing an adamantane fragment and the evaluation of their activity against the vaccinia virus, offering a possible mechanism of the antiviral action of the synthesized agents. Among all the studied adamantane derivatives, three compounds (2, 4, and 12) were found to demonstrate the highest antiviral activity, with the most promising compound 2 (N-(adamantan-1-yl)isonicotinamide) having the lowest toxicity level with a selectivity index (SI) of 115. The pharmacophoric profiles of these compounds are similar to the pharmacophoric profile of tecovirimat, an inhibitor of the membrane viral protein p37. Analysis of the results of molecular modeling suggests that the investigated compounds can inhibit the vaccinia virus by suppressing the phospholipase activity of membrane viral protein p37.

Authors

Institutions

Publication Details

Journal
Chemistry
Published
2025-03-01
DOI
https://doi.org/10.3390/chemistry7020034
Citations
3
Primary Topic
Herpesvirus Infections and Treatments
Type
article
Field-Weighted Citation Impact
4.06

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-Orthopoxvirus Activity of Amantadine and Rimantadine Derivatives—In Vitro Testing and Molecular Modeling

Olga А. Serova, Е. А. Дикусар, Alexey Yu. Fedorov, В. И. Поткин et al.
3 citations
Chemistry
Herpesvirus Infections and Treatments
4.06
article

Anti-Orthopoxvirus Activity of Amantadine and Rimantadine Derivatives—In Vitro Testing and Molecular Modeling

Olga А. Serova, Е. А. Дикусар, Alexey Yu. Fedorov, В. И. Поткин, Оlga I. Yarovaya, Shishkina Ln, Sophia S. Borisevich, Sergey G. Arkhipov, Е. А. Akishina, Нариман Ф. Салахутдинов, Э. М. Хамитов, Ivan A. Moskalev, Nikolay I. Bormotov
article en
3 citations

Abstract

In 2022, the number of mpox cases spiked worldwide, leading to a surge in scientific research on members of the Orthopoxvirus genus and the discovery of new compounds exhibiting anti-orthopoxvirus activity. This work is devoted to the synthesis of compounds containing an adamantane fragment and the evaluation of their activity against the vaccinia virus, offering a possible mechanism of the antiviral action of the synthesized agents. Among all the studied adamantane derivatives, three compounds (2, 4, and 12) were found to demonstrate the highest antiviral activity, with the most promising compound 2 (N-(adamantan-1-yl)isonicotinamide) having the lowest toxicity level with a selectivity index (SI) of 115. The pharmacophoric profiles of these compounds are similar to the pharmacophoric profile of tecovirimat, an inhibitor of the membrane viral protein p37. Analysis of the results of molecular modeling suggests that the investigated compounds can inhibit the vaccinia virus by suppressing the phospholipase activity of membrane viral protein p37.

ChemistryVol. 7(2)
National Academy of Sciences of Belarus (BY), State Research Center of Virology and Biotechnology VECTOR (RU), Novosibirsk Institute of Organic Chemistry (RU), Ufa Institute of Chemistry (RU), Siberian Branch of the Russian Academy of Sciences (RU)
Ministry of Science and Higher Education of the Russian Federation
Openalex Percentile: Top 7%
Herpesvirus Infections and Treatments
4.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.